You are here

Smoking cigarettes or other tobacco products

Document

Pulmonary thromboembolism - Smoking cigarettes or other tobacco products Factor

Last reviewed for CCPS 23 March 2001.

Investigative Documents

Claimant Report - Smoking [CRD905]

Claimant Report - Smoking [CRV905]

Preliminary questions [30302]

30303

the veteran has smoked cigarettes, cigars or pipe tobacco at some time.

30330the veteran has established the causal connection between the smoking of cigarettes or other tobacco products and VEA service for the clinical onset of pulmonary thromboembolism.

30331the veteran has established the causal connection between the smoking of cigarettes or other tobacco products and operational service for the clinical onset of pulmonary thromboembolism.

or

30332the veteran has established the causal connection between the smoking of cigarettes or other tobacco products and eligible service for the clinical onset of pulmonary thromboembolism.

Clinical onset and operational service [30331]

30333

the veteran smoked at least 15 cigarettes per day or the equivalent thereof in other tobacco products for a period of at least 90 days before the clinical onset of the condition under consideration and, where smoking has ceased, the clinical onset of the condition under consideration has occurred within 90 days of cessation.

30335

smoking as a causal result of operational service made a material contribution to the Statement of Principles requirements for the clinical onset of pulmonary thromboembolism.

Clinical onset and eligible service [30332]

30334

the veteran smoked at least 35 cigarettes per day or the equivalent thereof in other tobacco products for a period of at least 90 days before the clinical onset of the condition under consideration and, where smoking has ceased, the clinical onset of the condition under consideration has occurred within 90 days of cessation.

30336

smoking as a causal result of eligible service made a material contribution to the Statement of Principles requirements for the clinical onset of pulmonary thromboembolism.